$3.38
arrow_drop_down5.70%Key Stats | |
---|---|
Open | $3.62 |
Prev. Close | $3.59 |
EPS | -4.02 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
Market Cap | $182.70M |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 3.37 | 3.72 |
52 Week Range | 2.89 | 20.52 |
Ratios | |
---|---|
Revenue | - |
EPS | -4.02 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Bragar Eagel & Squire, P.C. Is Investigating Arhaus, Cardlytics, and CVRx and Encourages Investors to Contact the Firm
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
Cardlytics (CDLX) Under Investor Scrutiny About Growth Initiatives – Hagens Berman
A Glimpse Into The Expert Outlook On Cardlytics Through 7 Analysts
Why Cardlytics Stock Collapsed on Thursday